Loading…

SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis

SOX transcription factors are essential for embryonic development and play critical roles in cell fate determination, differentiation and proliferation. We previously reported that the SOX2 protein is expressed in normal gastric mucosae but downregulated in some human gastric carcinomas. To clarify...

Full description

Saved in:
Bibliographic Details
Published in:British journal of cancer 2008-02, Vol.98 (4), p.824-831
Main Authors: Otsubo, T, Akiyama, Y, Yanagihara, K, Yuasa, Y
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c604t-c820688b48f1e431666ec04ee93ce5fd2434b3a5cff588891f370f90e290a0503
cites cdi_FETCH-LOGICAL-c604t-c820688b48f1e431666ec04ee93ce5fd2434b3a5cff588891f370f90e290a0503
container_end_page 831
container_issue 4
container_start_page 824
container_title British journal of cancer
container_volume 98
creator Otsubo, T
Akiyama, Y
Yanagihara, K
Yuasa, Y
description SOX transcription factors are essential for embryonic development and play critical roles in cell fate determination, differentiation and proliferation. We previously reported that the SOX2 protein is expressed in normal gastric mucosae but downregulated in some human gastric carcinomas. To clarify the roles of SOX2 in gastric carcinogenesis, we carried out functional characterisation of SOX2 in gastric epithelial cell lines. Exogenous expression of SOX2 suppressed cell proliferation in gastric epithelial cell lines. Flow cytometry analysis revealed that SOX2-overexpressing cells exhibited cell-cycle arrest and apoptosis. We found that SOX2-mediated cell-cycle arrest was associated with decreased levels of cyclin D1 and phosphorylated Rb, and an increased p27 Kip1 level. These cells exhibited further characteristics of apoptosis, such as DNA laddering and caspase-3 activation. SOX2 hypermethylation signals were observed in some cultured and primary gastric cancers with no or weak SOX2 expression. Among the 52 patients with advanced gastric cancers, those with cancers showing SOX2 methylation had a significantly shorter survival time than those without this methylation ( P =0.0062). Hence, SOX2 plays important roles in growth inhibition through cell-cycle arrest and apoptosis in gastric epithelial cells, and the loss of SOX2 expression may be related to gastric carcinogenesis and poor prognosis.
doi_str_mv 10.1038/sj.bjc.6604193
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2259184</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1431365271</sourcerecordid><originalsourceid>FETCH-LOGICAL-c604t-c820688b48f1e431666ec04ee93ce5fd2434b3a5cff588891f370f90e290a0503</originalsourceid><addsrcrecordid>eNp1kc2LFDEQxYMo7uzq1ZsShPXWs5WkP5KLIItfsLAHFbyFdCbdnaYnGZO0y_z3ZnbaWRU8hdT71UtVHkIvCKwJMH4Vx3U76nVdQ0kEe4RWpGK0IJw2j9EKAJoCBIUzdB7jmK8CePMUnWW95qXgK5S-3H6n2EbcBfNjNi5Ne7zxdy6Yfp5UMhtsHe5VTMFqrJXTJkSs3KE82NamiLWZJtwHf5cGnIbg5364rxV6ryeDVQgmpvsWtfO75KONz9CTTk3RPF_OC_Ttw_uv15-Km9uPn6_f3RQ6r5MKzSnUnLcl74gpGanr2mgojRFMm6rb0JKVLVOV7rqKcy5IxxroBBgqQEEF7AK9Pfru5nZrNjqvF9Qkd8FuVdhLr6z8W3F2kL3_KSmtBOFlNnizGASffycmubXxsJxyxs9RElExYMAz-PofcPRzcHm57CUEb4AcoPUR0sHHGEx3moSAPKQp4yhzmnJJMze8-nP-B3yJLwOXC6CiVlMXckA2njgKpOE1IZm7OnIxS6434WG8_z798tjhVJqDOVn-1n8BJ-LETQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229987018</pqid></control><display><type>article</type><title>SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis</title><source>PubMed Central(OpenAccess)</source><creator>Otsubo, T ; Akiyama, Y ; Yanagihara, K ; Yuasa, Y</creator><creatorcontrib>Otsubo, T ; Akiyama, Y ; Yanagihara, K ; Yuasa, Y</creatorcontrib><description>SOX transcription factors are essential for embryonic development and play critical roles in cell fate determination, differentiation and proliferation. We previously reported that the SOX2 protein is expressed in normal gastric mucosae but downregulated in some human gastric carcinomas. To clarify the roles of SOX2 in gastric carcinogenesis, we carried out functional characterisation of SOX2 in gastric epithelial cell lines. Exogenous expression of SOX2 suppressed cell proliferation in gastric epithelial cell lines. Flow cytometry analysis revealed that SOX2-overexpressing cells exhibited cell-cycle arrest and apoptosis. We found that SOX2-mediated cell-cycle arrest was associated with decreased levels of cyclin D1 and phosphorylated Rb, and an increased p27 Kip1 level. These cells exhibited further characteristics of apoptosis, such as DNA laddering and caspase-3 activation. SOX2 hypermethylation signals were observed in some cultured and primary gastric cancers with no or weak SOX2 expression. Among the 52 patients with advanced gastric cancers, those with cancers showing SOX2 methylation had a significantly shorter survival time than those without this methylation ( P =0.0062). Hence, SOX2 plays important roles in growth inhibition through cell-cycle arrest and apoptosis in gastric epithelial cells, and the loss of SOX2 expression may be related to gastric carcinogenesis and poor prognosis.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/sj.bjc.6604193</identifier><identifier>PMID: 18268498</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Apoptosis ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Blotting, Western ; Cancer Research ; Caspases - metabolism ; Cell Cycle ; Cell growth ; Cell Proliferation ; Cyclin-Dependent Kinase Inhibitor p27 ; DNA Methylation ; DNA-Binding Proteins - antagonists &amp; inhibitors ; DNA-Binding Proteins - genetics ; DNA-Binding Proteins - metabolism ; Down-Regulation ; Drug Resistance ; Epidemiology ; Flow Cytometry ; Gastric cancer ; Gastroenterology. Liver. Pancreas. Abdomen ; Gene Silencing ; Genes ; HMGB Proteins - antagonists &amp; inhibitors ; HMGB Proteins - genetics ; HMGB Proteins - metabolism ; Humans ; Intracellular Signaling Peptides and Proteins - metabolism ; Medical prognosis ; Medical research ; Medical sciences ; Molecular Diagnostics ; Molecular Medicine ; Oncology ; Phosphorylation ; Proteins ; Retinoblastoma Protein ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; RNA, Small Interfering - pharmacology ; SOXB1 Transcription Factors ; Stomach Neoplasms - metabolism ; Stomach Neoplasms - pathology ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Transcription factors ; Transcription Factors - antagonists &amp; inhibitors ; Transcription Factors - genetics ; Transcription Factors - metabolism ; Tumor Cells, Cultured ; Tumors</subject><ispartof>British journal of cancer, 2008-02, Vol.98 (4), p.824-831</ispartof><rights>The Author(s) 2008</rights><rights>2008 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Feb 26, 2008</rights><rights>Copyright © 2008 Cancer Research UK 2008 Cancer Research UK</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c604t-c820688b48f1e431666ec04ee93ce5fd2434b3a5cff588891f370f90e290a0503</citedby><cites>FETCH-LOGICAL-c604t-c820688b48f1e431666ec04ee93ce5fd2434b3a5cff588891f370f90e290a0503</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259184/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259184/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20178611$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18268498$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Otsubo, T</creatorcontrib><creatorcontrib>Akiyama, Y</creatorcontrib><creatorcontrib>Yanagihara, K</creatorcontrib><creatorcontrib>Yuasa, Y</creatorcontrib><title>SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><description>SOX transcription factors are essential for embryonic development and play critical roles in cell fate determination, differentiation and proliferation. We previously reported that the SOX2 protein is expressed in normal gastric mucosae but downregulated in some human gastric carcinomas. To clarify the roles of SOX2 in gastric carcinogenesis, we carried out functional characterisation of SOX2 in gastric epithelial cell lines. Exogenous expression of SOX2 suppressed cell proliferation in gastric epithelial cell lines. Flow cytometry analysis revealed that SOX2-overexpressing cells exhibited cell-cycle arrest and apoptosis. We found that SOX2-mediated cell-cycle arrest was associated with decreased levels of cyclin D1 and phosphorylated Rb, and an increased p27 Kip1 level. These cells exhibited further characteristics of apoptosis, such as DNA laddering and caspase-3 activation. SOX2 hypermethylation signals were observed in some cultured and primary gastric cancers with no or weak SOX2 expression. Among the 52 patients with advanced gastric cancers, those with cancers showing SOX2 methylation had a significantly shorter survival time than those without this methylation ( P =0.0062). Hence, SOX2 plays important roles in growth inhibition through cell-cycle arrest and apoptosis in gastric epithelial cells, and the loss of SOX2 expression may be related to gastric carcinogenesis and poor prognosis.</description><subject>Apoptosis</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Blotting, Western</subject><subject>Cancer Research</subject><subject>Caspases - metabolism</subject><subject>Cell Cycle</subject><subject>Cell growth</subject><subject>Cell Proliferation</subject><subject>Cyclin-Dependent Kinase Inhibitor p27</subject><subject>DNA Methylation</subject><subject>DNA-Binding Proteins - antagonists &amp; inhibitors</subject><subject>DNA-Binding Proteins - genetics</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Down-Regulation</subject><subject>Drug Resistance</subject><subject>Epidemiology</subject><subject>Flow Cytometry</subject><subject>Gastric cancer</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gene Silencing</subject><subject>Genes</subject><subject>HMGB Proteins - antagonists &amp; inhibitors</subject><subject>HMGB Proteins - genetics</subject><subject>HMGB Proteins - metabolism</subject><subject>Humans</subject><subject>Intracellular Signaling Peptides and Proteins - metabolism</subject><subject>Medical prognosis</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Molecular Diagnostics</subject><subject>Molecular Medicine</subject><subject>Oncology</subject><subject>Phosphorylation</subject><subject>Proteins</subject><subject>Retinoblastoma Protein</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>RNA, Small Interfering - pharmacology</subject><subject>SOXB1 Transcription Factors</subject><subject>Stomach Neoplasms - metabolism</subject><subject>Stomach Neoplasms - pathology</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Transcription factors</subject><subject>Transcription Factors - antagonists &amp; inhibitors</subject><subject>Transcription Factors - genetics</subject><subject>Transcription Factors - metabolism</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp1kc2LFDEQxYMo7uzq1ZsShPXWs5WkP5KLIItfsLAHFbyFdCbdnaYnGZO0y_z3ZnbaWRU8hdT71UtVHkIvCKwJMH4Vx3U76nVdQ0kEe4RWpGK0IJw2j9EKAJoCBIUzdB7jmK8CePMUnWW95qXgK5S-3H6n2EbcBfNjNi5Ne7zxdy6Yfp5UMhtsHe5VTMFqrJXTJkSs3KE82NamiLWZJtwHf5cGnIbg5364rxV6ryeDVQgmpvsWtfO75KONz9CTTk3RPF_OC_Ttw_uv15-Km9uPn6_f3RQ6r5MKzSnUnLcl74gpGanr2mgojRFMm6rb0JKVLVOV7rqKcy5IxxroBBgqQEEF7AK9Pfru5nZrNjqvF9Qkd8FuVdhLr6z8W3F2kL3_KSmtBOFlNnizGASffycmubXxsJxyxs9RElExYMAz-PofcPRzcHm57CUEb4AcoPUR0sHHGEx3moSAPKQp4yhzmnJJMze8-nP-B3yJLwOXC6CiVlMXckA2njgKpOE1IZm7OnIxS6434WG8_z798tjhVJqDOVn-1n8BJ-LETQ</recordid><startdate>20080226</startdate><enddate>20080226</enddate><creator>Otsubo, T</creator><creator>Akiyama, Y</creator><creator>Yanagihara, K</creator><creator>Yuasa, Y</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20080226</creationdate><title>SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis</title><author>Otsubo, T ; Akiyama, Y ; Yanagihara, K ; Yuasa, Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c604t-c820688b48f1e431666ec04ee93ce5fd2434b3a5cff588891f370f90e290a0503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Apoptosis</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Blotting, Western</topic><topic>Cancer Research</topic><topic>Caspases - metabolism</topic><topic>Cell Cycle</topic><topic>Cell growth</topic><topic>Cell Proliferation</topic><topic>Cyclin-Dependent Kinase Inhibitor p27</topic><topic>DNA Methylation</topic><topic>DNA-Binding Proteins - antagonists &amp; inhibitors</topic><topic>DNA-Binding Proteins - genetics</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Down-Regulation</topic><topic>Drug Resistance</topic><topic>Epidemiology</topic><topic>Flow Cytometry</topic><topic>Gastric cancer</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gene Silencing</topic><topic>Genes</topic><topic>HMGB Proteins - antagonists &amp; inhibitors</topic><topic>HMGB Proteins - genetics</topic><topic>HMGB Proteins - metabolism</topic><topic>Humans</topic><topic>Intracellular Signaling Peptides and Proteins - metabolism</topic><topic>Medical prognosis</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Molecular Diagnostics</topic><topic>Molecular Medicine</topic><topic>Oncology</topic><topic>Phosphorylation</topic><topic>Proteins</topic><topic>Retinoblastoma Protein</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>RNA, Small Interfering - pharmacology</topic><topic>SOXB1 Transcription Factors</topic><topic>Stomach Neoplasms - metabolism</topic><topic>Stomach Neoplasms - pathology</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Transcription factors</topic><topic>Transcription Factors - antagonists &amp; inhibitors</topic><topic>Transcription Factors - genetics</topic><topic>Transcription Factors - metabolism</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Otsubo, T</creatorcontrib><creatorcontrib>Akiyama, Y</creatorcontrib><creatorcontrib>Yanagihara, K</creatorcontrib><creatorcontrib>Yuasa, Y</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Otsubo, T</au><au>Akiyama, Y</au><au>Yanagihara, K</au><au>Yuasa, Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>2008-02-26</date><risdate>2008</risdate><volume>98</volume><issue>4</issue><spage>824</spage><epage>831</epage><pages>824-831</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>SOX transcription factors are essential for embryonic development and play critical roles in cell fate determination, differentiation and proliferation. We previously reported that the SOX2 protein is expressed in normal gastric mucosae but downregulated in some human gastric carcinomas. To clarify the roles of SOX2 in gastric carcinogenesis, we carried out functional characterisation of SOX2 in gastric epithelial cell lines. Exogenous expression of SOX2 suppressed cell proliferation in gastric epithelial cell lines. Flow cytometry analysis revealed that SOX2-overexpressing cells exhibited cell-cycle arrest and apoptosis. We found that SOX2-mediated cell-cycle arrest was associated with decreased levels of cyclin D1 and phosphorylated Rb, and an increased p27 Kip1 level. These cells exhibited further characteristics of apoptosis, such as DNA laddering and caspase-3 activation. SOX2 hypermethylation signals were observed in some cultured and primary gastric cancers with no or weak SOX2 expression. Among the 52 patients with advanced gastric cancers, those with cancers showing SOX2 methylation had a significantly shorter survival time than those without this methylation ( P =0.0062). Hence, SOX2 plays important roles in growth inhibition through cell-cycle arrest and apoptosis in gastric epithelial cells, and the loss of SOX2 expression may be related to gastric carcinogenesis and poor prognosis.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>18268498</pmid><doi>10.1038/sj.bjc.6604193</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-0920
ispartof British journal of cancer, 2008-02, Vol.98 (4), p.824-831
issn 0007-0920
1532-1827
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2259184
source PubMed Central(OpenAccess)
subjects Apoptosis
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Blotting, Western
Cancer Research
Caspases - metabolism
Cell Cycle
Cell growth
Cell Proliferation
Cyclin-Dependent Kinase Inhibitor p27
DNA Methylation
DNA-Binding Proteins - antagonists & inhibitors
DNA-Binding Proteins - genetics
DNA-Binding Proteins - metabolism
Down-Regulation
Drug Resistance
Epidemiology
Flow Cytometry
Gastric cancer
Gastroenterology. Liver. Pancreas. Abdomen
Gene Silencing
Genes
HMGB Proteins - antagonists & inhibitors
HMGB Proteins - genetics
HMGB Proteins - metabolism
Humans
Intracellular Signaling Peptides and Proteins - metabolism
Medical prognosis
Medical research
Medical sciences
Molecular Diagnostics
Molecular Medicine
Oncology
Phosphorylation
Proteins
Retinoblastoma Protein
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger - genetics
RNA, Messenger - metabolism
RNA, Small Interfering - pharmacology
SOXB1 Transcription Factors
Stomach Neoplasms - metabolism
Stomach Neoplasms - pathology
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Transcription factors
Transcription Factors - antagonists & inhibitors
Transcription Factors - genetics
Transcription Factors - metabolism
Tumor Cells, Cultured
Tumors
title SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T08%3A04%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SOX2%20is%20frequently%20downregulated%20in%20gastric%20cancers%20and%20inhibits%20cell%20growth%20through%20cell-cycle%20arrest%20and%20apoptosis&rft.jtitle=British%20journal%20of%20cancer&rft.au=Otsubo,%20T&rft.date=2008-02-26&rft.volume=98&rft.issue=4&rft.spage=824&rft.epage=831&rft.pages=824-831&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1038/sj.bjc.6604193&rft_dat=%3Cproquest_pubme%3E1431365271%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c604t-c820688b48f1e431666ec04ee93ce5fd2434b3a5cff588891f370f90e290a0503%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=229987018&rft_id=info:pmid/18268498&rfr_iscdi=true